Sponsor or institution

Clinical trials and research at University College, London

• 73Clinical trials
• 32NIH research projects
• 1New in 30 days
• 24Countries

Newest trials

All recruiting trials (73)

• Monitoring and Early Detection of Treatable Inherited Retinal Disease in Children and Adolescents

  This study tests AI tools to spot and track inherited retinal diseases caused by RPE65 and RPGR mutations using widefield eye images in kids and teens.

  Recruiting University College, London · Boston, Massachusetts and 2 other locations · NCT07901907

• Oral Progestin Tablets With Radiotherapy vs. Standard Radiotherapy and Chemotherapy in High-Risk NSMP Endometrial Cancer

  This trial tests whether adding oral progestin tablets after radiotherapy is as effective as the standard radiotherapy plus chemotherapy for high-risk NSMP endometrial cancer, hoping to reduce side effects and improve quality of life.

  Recruiting at 12 sites Phase 3 University College, London · Bath and 11 other locations · NCT07831902

• MIGHTY: CAR T cells targeting B7-H3 for pediatric, teen, and young adult sarcoma

  This Phase 1 trial tests autologous hBRCA84D CAR T cells in kids, teens, and young adults (1–24) with relapsed or refractory RMS, ES, or DSRCT to see if the therapy is feasible and safe.

  Recruiting at 2 sites Phase 1 University College, London · London and 1 other locations · NCT07751380

• Lower-dose ARPI therapy for metastatic prostate cancer

  This trial tests whether using half the usual dose of ARPI therapy can work as well as a full dose for men with metastatic prostate cancer who are also receiving standard hormone therapy.

  Recruiting at 4 sites Phase 3 University College, London · Huddersfield and 3 other locations · NCT07751133

• Treatments for sustained improvement in symptomatic Alzheimer’s disease (18 months)

  This trial tests whether adding atomoxetine or metformin to standard care helps people with Alzheimer’s disease or related dementia see lasting improvements over 18 months.

  Recruiting at 2 sites Phase 3 University College, London · Cambridge and 1 other locations · NCT07724132

• Impact of an accessory pudendal artery on erection recovery after nerve-sparing prostate surgery

  This study checks if preserving an extra artery (the accessory pudendal artery) during robotic prostate removal helps men regain erections after nerve-sparing surgery.

  Recruiting University College, London · London · NCT07597798

• Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma

  This study tests whether safely coagulating small branches of the middle meningeal artery during burr-hole drainage can reduce recurrence of chronic subdural haematoma in adults receiving standard surgical care.

  Recruiting University College, London · London · NCT07549893

• Urodynamics versus videourodynamics for women with recurrent stress urinary incontinence

  This trial will test whether videourodynamics or standard urodynamics before repeat surgery helps women with recurrent stress urinary incontinence get better treatment outcomes.

  Recruiting University College, London · London · NCT07542080

• LaserSAFE: Quick in OR imaging to check margins during prostatectomy

  A new in‑the‑operating‑room imaging method called LaserSAFE is tested to see if it can quickly detect cancer at the edge of the prostate during surgery for patients undergoing robot-assisted prostatectomy.

  Recruiting University College, London · London · NCT07541911

• Actinium (225Ac) PSMA therapy for castration‑resistant prostate cancer after Lutetium

  This trial will test whether an injectable Actinium-225 PSMA treatment can control advanced prostate cancer in men whose disease progressed after Lutetium‑PSMA therapy.

  Recruiting Phase 1/2 University College, London · London · NCT07414940

• Anti-CCR9 CAR T-cell therapy for T‑cell acute lymphoblastic leukaemia and lymphoblastic lymphoma

  We will try anti-CCR9 CAR T cells made from your own blood to find a dose that is safe for children and adults with relapsed or refractory T‑cell leukaemia or lymphoma.

  Recruiting Phase 1 University College, London · London · NCT07300683

• Edmond J. Safra Parkinson's multi-arm, multi-stage treatment platform

  This project tests whether adding telmisartan or terazosin (versus placebo) helps people with Parkinson's disease who are already taking Parkinson's medications.

  Recruiting at 2 sites Phase 3 University College, London · London and 1 other locations · NCT07207057

• Extended high-dose antibiotics plus methenamine hippurate versus standard low-dose antibiotics or methenamine hippurate for women with chronic urinary tract infection

  This study will try longer courses of higher-dose antibiotics together with methenamine hippurate to see if they reduce daily symptoms better than the usual low-dose antibiotics or methenamine in adult women with chronic urinary tract infection.

  Recruiting at 4 sites Phase 2 University College, London · Yorkshire, Humber and 4 other locations · NCT07202949

• Health impact of non-tuberculous mycobacteria (NTM) lung disease

  This project will try to see which symptoms matter most and which non-drug treatments help adults with NTM lung disease.

  Recruiting University College, London · London · NCT07192705

• Optimal treatment duration for radiographically apparent TB without bacteriological confirmation

  This trial tests the shortest effective TB treatment duration for people found by community chest X-rays to have TB-like signs but who lack bacteriological confirmation.

  Recruiting Phase 3 University College, London · Islamabad and 3 other locations · NCT07163143

• Bespoke Decision Support for Localised Prostate Cancer

  Aiming to see if a personalized decision aid helps men with a new localised prostate cancer choose a treatment with less worry or conflict.

  Recruiting University College, London · London · NCT07135271

• Giving immunotherapy before standard treatment for newly diagnosed glioblastoma

  This Phase 1 trial tests whether giving two doses of the immunotherapy drug ipilimumab before surgery is safe and may help people with newly diagnosed glioblastoma or gliosarcoma.

  Recruiting Phase 1 University College, London · London, Greater London · NCT07134842

• PRISM: A dashboard to help First Contact Physiotherapists see if patients' MSK pain is suitable for primary care care

  A feasibility test to see if a data dashboard can help First Contact Physiotherapists in UK GP practices identify appropriate MSK patients and standardize decisions.

  Recruiting at 2 sites University College, London · London and 1 other locations · NCT07112508

• Using entropy to detect sleep breathing problems in chronic lung disease

  This project will test whether entropy measurements from simple overnight oxygen and pulse recordings can find sleep-disordered breathing in adults with chronic lung conditions such as COPD, asthma, bronchiectasis, and interstitial lung disease.

  Recruiting University College, London · London · NCT07060079

• Finding undiagnosed chronic lung problems in people with other long-term health conditions in Brazil

  This project will try two short questionnaires (COLA and SBQ) plus breathing tests to find undiagnosed asthma, COPD, or similar lung problems in people with long-term conditions who attend primary care in São Carlos and São Paulo, Brazil.

  Recruiting University College, London · São Carlos, São Paulo and 1 other locations · NCT07050823

• Biomarker-guided decisions about preventive TB treatment

  This project tests what influences adults tested for latent TB when deciding whether to start preventive treatment.

  Recruiting University College, London · London · NCT07024836

• neoSCB app to screen newborns for jaundice

  This project will test whether the neoSCB smartphone app can accurately detect significant jaundice in newborn babies by photographing the white part of the eye.

  Recruiting University College, London · London · NCT06963450

• Robotic Mako cementless versus cemented total knee replacement

  This study will test whether robotic Mako cementless or cemented knee replacements work better for adults having a primary total knee replacement for osteoarthritis.

  Recruiting University College, London · London · NCT06929871

• Adaptive deep brain stimulation for children with Lennox–Gastaut syndrome

  This trial will test adaptive deep brain stimulation using the Picostim device to try to reduce seizures in children aged 5–14 with Lennox–Gastaut syndrome.

  Recruiting University College, London · London · NCT06924086

• Understanding Fuchs' Endothelial Corneal Dystrophy and its Genetic Links

  This study is trying to understand how Fuchs' Endothelial Corneal Dystrophy affects younger people with a genetic link to the condition by using advanced imaging to track changes over time.

  Recruiting University College, London · London · NCT06881771

• Sharing anonymized MRI data for small bowel diseases

  This study is sharing MRI scans and related health information from patients with small bowel diseases like Crohn's to see how well these scans can help doctors understand and treat these conditions.

  Recruiting University College, London · London · NCT06868875

• Digital program to prepare for psychedelic experiences using meditation or music

  This study is testing a 21-day digital program using either meditation or music to help healthy people prepare for a psilocybin experience and see how it affects their journey.

  Recruiting Phase 1 University College, London · London · NCT06815653

• Comparing MR Enterography and Ultrasound for Assessing Crohn's Disease Treatment Response

  This study is testing whether MR Enterography or Intestinal Ultrasound is better at showing how well treatment is working for people with Crohn's disease who are 16 and older.

  Recruiting University College, London · London · NCT06800326

• Understanding antibiotic resistance and microbiome changes in STI prevention

  This study is trying to see how using doxycycline for STI prevention affects antibiotic resistance and changes in gut bacteria in men who have sex with men.

  Recruiting University College, London · London · NCT06778083

• Isatuximab plus iberdomide and dexamethasone for people with intermediate- or high-risk smouldering myeloma

  This trial will test whether combining isatuximab, iberdomide, and dexamethasone can delay or prevent progression to active multiple myeloma in adults with intermediate- or high-risk smouldering myeloma.

  Recruiting at 14 sites Phase 2 University College, London · Leeds, Leeds and 13 other locations · NCT06762769

• Improving pelvic rehabilitation after spinal cord injury with epidural stimulation

  This study is testing if using a special device to stimulate the spinal cord can help people with spinal cord injuries improve their bladder and bowel function through pelvic rehabilitation.

  Recruiting University College, London · Stanmore · NCT06515223

• Comparing catheter ablation (cryo, radiofrequency, pulsed field) with medical therapy for people with atrial fibrillation and heart failure.

  This study will see if catheter ablation plus optimal heart-failure medicines helps people with atrial fibrillation and heart failure have fewer unplanned heart-failure hospital stays and lower risk of death than medicines alone.

  Recruiting at 24 sites University College, London · Halifax and 23 other locations · NCT06505798

• Exploring how physical activity affects depression

  This study is trying to see if doing aerobic exercise can help people with depression feel better compared to those doing stretching and relaxation exercises.

  Recruiting University College, London · London · NCT06387732

• NIO752 to reduce tau production measured with SILK

  This Phase 1 trial will test whether the drug NIO752 lowers production of the tau protein in people with mild to moderate Alzheimer's disease or with genetic APP/PSEN mutations.

  Recruiting at 2 sites Phase 1 University College, London · St Louis, Missouri and 1 other locations · NCT06372821

• Testing new treatments for metastatic hormone-sensitive prostate cancer

  This study is testing if new treatments for metastatic hormone-sensitive prostate cancer can help patients live longer and slow down the cancer compared to standard care.

  Recruiting at 18 sites Phase 3 University College, London · Barnsley and 17 other locations · NCT06320067

• Program for better living with non-memory-led dementia

  This study tests a support program for caregivers of people with non-memory-led dementias to see if it helps them manage their caregiving challenges better.

  Recruiting University College, London · London · NCT06241287

• Using smartphone technology to improve care for patients with cirrhosis

  This study is testing whether a new smartphone monitoring system can help people with advanced liver disease manage their condition better and avoid hospital visits compared to regular care.

  Recruiting at 14 sites University College, London · Birmingham and 14 other locations · NCT06223893

• Remote assessment for people with Parkinson's disease

  This study is testing whether an online questionnaire and saliva samples can help people with Parkinson's disease learn about their genetics and find out if they might qualify for future clinical trials.

  Recruiting University College, London · London · NCT06151002

• Using MRI to predict Crohn's disease relapse after stopping biologics

  This study is testing if MRI scans can help predict when people with Crohn's disease might have a relapse after stopping their medication.

  Recruiting University College, London · London · NCT06124287

• New treatments for pulmonary tuberculosis

  This study is testing new combinations of two drugs with existing TB treatments to see if they can help people with pulmonary tuberculosis get better in a shorter time than the usual 24 weeks.

  Recruiting at 8 sites Phase 2 University College, London · Chisinau and 10 other locations · NCT06114628

• Combination of drugs for treating relapsed large B-cell lymphoma before and after CAR-T therapy

  This study is testing a combination of three drugs to see if they can help people with relapsed large B-cell lymphoma feel better before and after CAR-T therapy.

  Recruiting at 5 sites Phase 2 University College, London · London and 4 other locations · NCT06071871

• Using spinal cord stimulation to improve upper limb rehabilitation

  This study is testing if adding a gentle spinal cord stimulation treatment to regular rehab can help people with recent spinal cord injuries improve their arm function and reduce stiffness.

  Recruiting University College, London · London · NCT05991804

• Developing new MRI techniques using healthy volunteers

  This study is testing new MRI techniques using healthy volunteers to see if they can make scans faster and better for future medical use.

  Recruiting University College, London · London · NCT05943249

• Evaluating new biomarkers for lung health checks

  This study is testing new biological markers in people getting lung health checks to see if they can help find serious lung cancers earlier and reduce unnecessary treatments.

  Recruiting University College, London · London · NCT05902559

• Understanding why CAR T cells don't last in leukemia treatment

  This study looks at kids and young adults with leukemia to see why CAR T cells don't stick around long enough after treatment and what might help them last longer.

  Recruiting at 3 sites University College, London · London and 2 other locations · NCT05809284

• Using ambroxol to slow down Parkinson's disease progression

  This study is testing if ambroxol, a medication usually for breathing problems, can help slow down the progression of Parkinson's disease in people over two years.

  Recruiting at 3 sites Phase 3 University College, London · Birmingham and 14 other locations · NCT05778617

• Selective stimulation of the vagus nerve using electrical impedance tomography

  This study is testing a new way to stimulate the vagus nerve to see if it can help treat conditions like epilepsy with fewer side effects.

  Recruiting University College, London · London, Greater London · NCT05664854

• Proton therapy for treating malignant pleural mesothelioma

  This study is testing if proton therapy can help people with malignant pleural mesothelioma live longer and feel better compared to standard care.

  Recruiting at 24 sites University College, London · Eastbourne, East Sussex and 24 other locations · NCT05655078

• Combining Zanubrutinib and Rituximab for Indolent Mantle Cell Lymphoma

  This study is testing if a new combination of two medications, zanubrutinib and rituximab, can help people with indolent mantle cell lymphoma who haven't been treated before.

  Recruiting at 13 sites Phase 2 University College, London · Derby and 12 other locations · NCT05635162

• Tracking lung cancer evolution through therapy

  This study is trying to see how lung cancer changes during treatment in people with different types of the disease by collecting health information and samples over two years.

  Recruiting University College, London · London · NCT05628376

• Comparing hemithyroidectomy and total thyroidectomy for low-risk thyroid cancers

  This study is testing whether a less extensive thyroid surgery is just as effective as a full thyroid removal for people with low-risk thyroid cancer.

  Recruiting at 30 sites University College, London · Crewe, Cheshire and 32 other locations · NCT05604963

• CAR T cell therapy targeting GD2 for treating Diffuse Midline Glioma in children

  This study is testing a new treatment using modified immune cells to see if it can help children and young adults with Diffuse Midline Glioma feel better and fight their cancer.

  Recruiting Phase 1 University College, London · London · NCT05544526

• Understanding why OCD therapy fails

  This study is trying to understand why therapy sometimes doesn't work for people with OCD by looking at their brain activity and behavior before and after treatment.

  Recruiting University College, London · London · NCT05520398

• Nicotinamide treatment for open-angle glaucoma

  This study is testing if a form of Vitamin B3 called Nicotinamide can help people with early to moderate open-angle glaucoma keep their vision from getting worse.

  Recruiting at 4 sites Phase 3 University College, London · Belfast, Northern Ireland and 9 other locations · NCT05405868

• KCAT19 T cells for relapsed or refractory B cell cancers

  This study tests KCAT19 T cells, a gene-modified cell therapy, in adults with high-risk B cell cancers that have come back or stopped responding to treatment.

  Recruiting Phase 1 University College, London · London · NCT05391490

• Impact of a preoperative exercise program on patients awaiting bariatric surgery

  This study tests if a four-week exercise program can help people getting ready for bariatric surgery improve their fitness, metabolism, and weight.

  Recruiting University College, London · London · NCT05235945

• Combination of pembrolizumab and lenvatinib for liver cancer treatment

  This study is testing whether a combination of two cancer drugs, pembrolizumab and lenvatinib, can help patients with liver cancer have better outcomes after surgery.

  Recruiting at 6 sites Phase 2 University College, London · Birmingham and 10 other locations · NCT05185739

• Gene therapy for children with Ornithine Transcarbamylase deficiency

  This study is testing a new gene therapy for children with Ornithine Transcarbamylase deficiency to see if it can help their liver produce a missing enzyme and reduce dangerous ammonia levels in their blood.

  Recruiting Phase 1/2 University College, London · London · NCT05092685

• Adaptive chemotherapy approach for relapsed ovarian cancer

  This study is testing if adjusting the dose of carboplatin based on a blood marker can help women with relapsed ovarian cancer feel better and have fewer side effects from treatment.

  Recruiting Phase 2 University College, London · London · NCT05080556

• AI-assisted colonoscopy for diagnosing colorectal polyps

  This study is testing whether using an AI device during colonoscopy can help doctors find small colorectal polyps more accurately compared to a regular colonoscopy.

  Recruiting University College, London · London · NCT05064124

• Liver biopsy for patients with severe hemophilia after gene therapy

  This study is testing how gene therapy affects the liver in people with severe hemophilia who have already received the treatment, to learn more about its safety and effectiveness.

  Recruiting University College, London · London · NCT04817462

• Modular BCMA and BCMA/CD19 CAR T therapy for relapsed or refractory multiple myeloma

  This Phase 1 trial will test two CAR T approaches—BCMA-only and BCMA-plus-CD19—in adults with relapsed or refractory multiple myeloma who have had at least three prior treatments.

  Recruiting Phase 1 University College, London · London, County (Optional) · NCT04795882

• Brentuximab vedotin for early stage Hodgkin lymphoma treatment

  This study is testing if adding a new drug called brentuximab vedotin to standard chemotherapy can help people with early-stage Hodgkin lymphoma do better in their treatment.

  Recruiting at 72 sites Phase 3 University College, London · Stanford, California and 71 other locations · NCT04685616

• Mapping lymph nodes in oropharyngeal cancer patients

  This study is testing a new way to find important lymph nodes in patients with oropharyngeal cancer to see if it can help doctors make better treatment choices and avoid unnecessary side effects.

  Recruiting at 2 sites University College, London · London and 1 other locations · NCT04498221

• Improving outcomes for patients with osteosarcoma

  This study is trying to gather information and samples from people with osteosarcoma to better understand the disease and find ways to improve treatment and outcomes.

  Recruiting at 22 sites University College, London · London, Greater London and 21 other locations · NCT04132895

• Combination of Durvalumab and Cancer Vaccine for Bladder Cancer

  This study is testing a new combination of a cancer vaccine and an immune therapy to see if it can help people with bladder cancer that hasn't responded to standard treatment.

  Recruiting at 7 sites Phase 1/2 University College, London · Cambridge and 6 other locations · NCT04106115

• Comparing two methods of knee replacement surgery

  This study tests whether a robotic knee replacement surgery works better than a traditional method for people with knee osteoarthritis.

  Recruiting University College, London · London · NCT04095637

• Comparing two treatment approaches for Waldenström's macroglobulinaemia

  This study is testing a new treatment without chemotherapy for people with Waldenström's macroglobulinaemia to see if it works better and is easier on the body than the standard treatment.

  Recruiting at 25 sites Phase 2/3 University College, London · Bath and 24 other locations · NCT04061512

• Testing new treatments for kidney cancer after surgery

  This study is testing if a new kidney cancer treatment, either by itself or in combination, can help patients stay cancer-free longer after surgery compared to just monitoring their health.

  Recruiting at 35 sites Phase 3 University College, London · Aberdeen and 34 other locations · NCT03288532

• Collecting cerebrospinal fluid to aid in developing treatments for Huntington's disease

  This study is collecting spinal fluid and blood samples from people with Huntington's disease to help find better treatments for the condition.

  Recruiting at 32 sites University College, London · Englewood, Colorado and 39 other locations · NCT02855476

• Identifying genetic factors in Parkinson's disease families

  This study is trying to find new genes that might cause Parkinson's disease in younger people and those with family members who have it, to help improve diagnosis and treatment options.

  Recruiting at 2 sites University College, London · London and 1 other locations · NCT02760108

• Immunotherapy using CAR T-cells for treating high-risk acute lymphoblastic leukaemia

  This study is testing a new type of immune therapy using specially modified T-cells to see if it can help children and young adults with high-risk leukemia feel better and stay in remission longer.

  Recruiting at 3 sites Phase 1 University College, London · London and 2 other locations · NCT02443831

• Focal therapy using high-intensity focused ultrasound for prostate cancer

  This study is testing whether high-intensity focused ultrasound can effectively treat localized prostate cancer while causing fewer side effects compared to standard treatments.

  Recruiting University College, London · London, England · NCT01194648

NIH-funded research (32)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• English Longitudinal Study of Ageing: Renewal to Track Dementia and Healthy Aging

  A long-term national study will continue to collect data on aging, health, cognition, and daily living to help understand how aging and Alzheimer’s-related conditions affect people in the UK and beyond.

  NIH research University College London · London, United Kingdom · NIH-11536553

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A computer program helps plan radiation therapy for cervical and head-and-neck cancer patients to make treatments faster and more accurate.

  NIH research University College London · London, United Kingdom · NIH-11535419

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A United Kingdom study is testing AI software that helps plan radiotherapy for cervical and head-and-neck cancer patients to save time and reduce the workload for clinicians in low-resource settings.

  NIH research University College London · London, United Kingdom · NIH-11535418

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A UK research team is testing an AI-based software to automatically outline cancer areas and plan radiation beams to speed up treatment for cervical and head-and-neck cancers in LMICs.

  NIH research University College London · London, United Kingdom · NIH-11535417

• AI-Powered Radiotherapy Planning for Cervical and Head & Neck Cancer

  A new AI tool helps plan radiation therapy for cervical and head-and-neck cancers to save time and reduce the need for specialized staff.

  NIH research University College London · London, United Kingdom · NIH-11535416

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A UK study from University College London uses AI to plan radiotherapy for cervical and head-and-neck cancers to save time and reduce the need for specialized staff, aiming to help patients in LMICs.

  NIH research University College London · London, United Kingdom · NIH-11535415

• AI-powered radiotherapy planning for cervical and head & neck cancer

  A non-randomized study will test an AI system that helps plan radiotherapy for cervical and head & neck cancers to save time and resources in LMICs.

  NIH research University College London · London, United Kingdom · NIH-11535414

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A UK-led study is testing an AI system that helps plan and optimize radiotherapy for cervical and head-and-neck cancer to reduce wait times and required staff.

  NIH research University College London · London, United Kingdom · NIH-11535413

• AI-powered radiotherapy planning for cervical and head-and-neck cancer

  A new AI-based system helps doctors plan cervical and head-and-neck cancer radiotherapy faster and with less labor, aiming to reach more patients, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11415643

• Advancing Behavioral Cancer Prevention with Ontology Tools

  This project develops and expands a semantic tool (BCIO) to improve clarity and consistency in cancer prevention research that focuses on behavior change.

  NIH research University College London · London, United Kingdom · NIH-11411326

• AI-assisted radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to create radiotherapy treatment plans faster and with fewer specialists for people with cervical or head and neck cancers, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11399435

• AI-assisted radiotherapy planning for cervical and head and neck cancers

  This project uses artificial intelligence to create radiotherapy treatment plans faster and with less specialist time for people with cervical and head and neck cancers, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11399434

• AI-guided radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to speed up and standardize radiation treatment planning for people with cervical or head and neck cancer, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11399433

• AI-assisted radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to make radiotherapy planning faster and more accurate for people with cervical or head and neck cancer, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11399432

• AI-assisted radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to speed up and improve radiotherapy planning for people with cervical or head and neck cancer, especially in areas with limited specialist staff.

  NIH research University College London · London, United Kingdom · NIH-11399431

• AI-powered radiotherapy planning for cervical and head and neck cancer

  This project uses AI software to create radiation treatment plans more quickly and accurately for people with cervical or head and neck cancer, especially in low- and middle-income countries.

  NIH research University College London · London, United Kingdom · NIH-11399430

• AI-guided radiation planning for cervical and head and neck cancers

  AI software creates radiation treatment plans faster and with less staff for people with cervical or head and neck cancer.

  NIH research University College London · London, United Kingdom · NIH-11399429

• AI-powered radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to create faster, accurate radiotherapy plans for people with cervical or head and neck cancer so more patients can get timely treatment.

  NIH research University College London · London, United Kingdom · NIH-11399428

• English Longitudinal Study of Ageing renewal to study aging, health, and dementia

  A long-running study in older adults is being renewed to collect more data on aging, health, and brain changes, including dementia, so researchers can better understand what affects healthy aging.

  NIH research University College London · London, United Kingdom · NIH-11399284

• Tracking health, thinking, and daily life in older adults in England

  Regularly collects health, memory, daily-activity and social information from older adults in England so researchers can learn what leads to dementia and healthier aging.

  NIH research University College London · London, United Kingdom · NIH-11382668

• Why some brains resist tau-related damage in Alzheimer's and related dementias

  Researchers are using genetically diverse mice that carry a human tau mutation to find genes that help brains resist the tau changes behind Alzheimer's and related dementias.

  NIH research University College London · London, United Kingdom · NIH-11248861

• AI-assisted radiotherapy planning for cervical and head and neck cancer

  This project uses artificial intelligence to speed up and improve radiotherapy plans for people with cervical or head and neck cancer.

  NIH research University College London · London, United Kingdom · NIH-11176033

• English Longitudinal Ageing (ELSA) — waves 12–13 and HCAP

  Collects health, memory, activity, and social information from adults aged 50+ in England to track aging and dementia risk over time.

  NIH research University College London · London, United Kingdom · NIH-11087552

• Investigating genetic factors that influence resilience to tau-related brain diseases.

  This study is looking at how our genes might help some people be more resilient to tau-related issues in Alzheimer's and similar conditions, using special mice to find clues that could lead to new treatments or ways to prevent these diseases.

  NIH research University College London · London, United Kingdom · NIH-11053899

• Creating a large database of T cell receptors and their interactions with cancer antigens

  This study is looking at how certain immune cells recognize cancer markers, which could help create better treatments for cancer patients using their own immune systems.

  NIH research University College London · London, United Kingdom · NIH-11046700

• Targeting protein degradation to treat childhood tumors

  This study is working on new and better treatments for kids with solid tumors, especially brain tumors, by focusing on specific proteins that help these tumors grow, so that young patients can have more effective options beyond the usual chemotherapy and radiation.

  NIH research University College London · London, United Kingdom · NIH-11045813

• Improving cancer prevention through better understanding of behavior change.

  This study is working on a way to make it easier for researchers to share and understand how different behaviors, like quitting smoking or being more active, can help prevent cancer, so they can create better tools to support people in making healthy changes.

  NIH research University College London · London, United Kingdom · NIH-10938088

• Using Natural Killer cells to fight HIV and HBV co-infection

  This study is looking at how special immune cells called Natural Killer (NK) cells can help improve treatment for people who have both HIV and Hepatitis B, by exploring how these cells work in the body to fight off the viruses.

  NIH research University College London · London, United Kingdom · NIH-10869949

• Using AI to improve radiotherapy planning for cervical and head and neck cancers

  This study is testing a new AI tool to make planning radiation treatment for cervical and head and neck cancers faster and easier, so patients can get the care they need more quickly, especially in places where resources are limited.

  NIH research University College London · London, United Kingdom · NIH-10690469

• New T cell therapies for childhood cancers

  This study is working on creating special treatments using T cells to help kids with tough-to-treat solid cancers, like certain types of sarcomas and brain tumors, by making these immune cells better at finding and fighting cancer cells.

  NIH research University College London · London, United Kingdom · NIH-10631014

• Investigating how cancer cells use circular DNA to grow and resist treatment

  This study is looking at a special type of DNA found in some cancers that helps tumors grow and resist treatment, and it's aimed at finding new ways to help patients with these tumors get better care.

  NIH research University College London · London, United Kingdom · NIH-10627284

• Understanding and addressing cancer cachexia

  This study is looking into cancer cachexia, a tough condition that causes weight loss and muscle loss in many cancer patients, to understand how tumors affect the body's metabolism, with the hope of finding better treatments to help improve patients' lives.

  NIH research University College London · London, United Kingdom · NIH-10627283

Quick answers

How many clinical trials run by University College, London are recruiting right now?

73, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in United Kingdom (70 trials), United States (4 trials), Canada (3 trials), Germany (2 trials), New Zealand (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 10, Phase 1: 9, Phase 2: 7, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →